Abstract
Simple antibodies or vector-induced T cell immunity are unable to provide broad immunity to HIV. Although broadly reactive neutralising antibodies are a goal of vaccination, this remains elusive. There is growing evidence that HIV-specific antibodies that mediate their activity via the Fc-receptor, such as antibody dependent cellular cytotoxicity (ADCC), have an important role in controlling HIV infection. Newer assays are being developed that enable HIV-specific ADCC responses to be finely mapped. In turn, this should allow a more definitive analysis of the effectiveness of HIVspecific ADCC antibodies. However, progressive dysfunction of effector cells that mediate ADCC responses, such as NK cells, combined with immune escape variants that emerge from effective ADCC responses, likely undermine the utility of ADCC responses during chronic HIV infection. Nonetheless the utility of ADCC responses in preventing HIV infection requires urgent consideration.
Keywords: HIV, antibodies, ADCC, vaccine
Current HIV Research
Title: The Utility of ADCC Responses in HIV Infection
Volume: 6 Issue: 6
Author(s): Amy Chung, Erik Rollman, Susanne Johansson, Stephen J. Kent and Ivan Stratov
Affiliation:
Keywords: HIV, antibodies, ADCC, vaccine
Abstract: Simple antibodies or vector-induced T cell immunity are unable to provide broad immunity to HIV. Although broadly reactive neutralising antibodies are a goal of vaccination, this remains elusive. There is growing evidence that HIV-specific antibodies that mediate their activity via the Fc-receptor, such as antibody dependent cellular cytotoxicity (ADCC), have an important role in controlling HIV infection. Newer assays are being developed that enable HIV-specific ADCC responses to be finely mapped. In turn, this should allow a more definitive analysis of the effectiveness of HIVspecific ADCC antibodies. However, progressive dysfunction of effector cells that mediate ADCC responses, such as NK cells, combined with immune escape variants that emerge from effective ADCC responses, likely undermine the utility of ADCC responses during chronic HIV infection. Nonetheless the utility of ADCC responses in preventing HIV infection requires urgent consideration.
Export Options
About this article
Cite this article as:
Chung Amy, Rollman Erik, Johansson Susanne, Kent J. Stephen and Stratov Ivan, The Utility of ADCC Responses in HIV Infection, Current HIV Research 2008; 6 (6) . https://dx.doi.org/10.2174/157016208786501472
DOI https://dx.doi.org/10.2174/157016208786501472 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
Management of HIV: Management of HIV: old challenges and new needs
The aim of this thematic issue is to provide the most recent updates regarding the effective management of HIV infection. Antiretroviral therapy (ART) has significantly decreased HIV-related mortality, leading to an enhancement in the quality of life and life expectancy for people living with HIV (PLWH). Despite the numerous advancements ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Unsaturation: An Important Structural Feature to Nucleosides’ Antiviral Activity
Anti-Infective Agents Magnetite Nanostructures with Applications in Cancer Therapy
Current Proteomics High Density DNA Microarrays: Algorithms and Biomedical Applications
Current Medicinal Chemistry The Molecular Bases of the Self-Renewal and Differentiation of Leukemic Stem Cells
Current Cancer Therapy Reviews Metabolic Acidosis in Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets T Cell Tuning for Tumour Therapy: Enhancing Effector Function and Memory Potential of Therapeutic T cells
Current Gene Therapy Hepatic Manifestations in Juvenile Systemic Lupus Erythematosus
Recent Patents on Inflammation & Allergy Drug Discovery Role of Oxidative Stress in Pathophysiological Progression of Schizophrenia
Current Psychiatry Research and Reviews Marine Actinomycetes-derived Natural Products
Current Topics in Medicinal Chemistry Role of the Hsp90-Immunophilin Heterocomplex in Cancer Biology
Current Cancer Therapy Reviews Meet Our Editorial Board Member
Current Signal Transduction Therapy Chronic Low Back Pain: Current Pharmacotherapeutic Therapies and a New Biological Approach
Current Medicinal Chemistry The Design of Experiment Approach, Rheology for Optimization of a Topical Anti-inflammatory and Analgesic Cream
Current Drug Delivery Cocaine and HIV-1 Interplay in CNS: Cellular and Molecular Mechanisms
Current HIV Research Immunometabolism in the Pathogenesis of Depressive Disorders - Therapeutic Considerations
Current Topics in Medicinal Chemistry Metal Allergens of Growing Significance: Epidemiology, Immunotoxicology, Strategies for Testing and Prevention
Inflammation & Allergy - Drug Targets (Discontinued) Toll-like Receptor 4 Regulation of Corneal Angiogenesis
Current Angiogenesis (Discontinued) Meet Our Editorial Board Member:
Medicinal Chemistry Mood-Stabilizers Target the Brain Arachidonic Acid Cascade
Current Molecular Pharmacology Extraction, Structure and Bioactivities of the Polysaccharides from Fructus corni
Recent Patents on Food, Nutrition & Agriculture